(BSNS WIRE) Nutraceutix Inc. Supplies D-Glucarate to Life Extension Foundat
Nutraceutix Inc. Supplies D-Glucarate to Life Extension Foundation
Business Editors & Health/Medical Writers
REDMOND, Wash.--(BW HealthWire)--Nov. 6, 2000--Nutraceutix Inc.
(OTCBB: NUTX), a leading provider of proven technologies and products
for the nutraceutical market, Monday announced it has sub-licensed and
will supply patented Calcium D-Glucarate(TM) to Life Extension
Foundation, of Fort Lauderdale, Fla., for Life Extension Mix, which
will include 200mg of standardized calcium D-Glucarate per daily dose.
Nutraceutix holds the exclusive license of Calcium D-Glucarate for
its benefits relating to breast, colon, liver, prostate and lung
health. Life Extension Foundation sells product via its
membership-based website, and provides health and product information
through its monthly magazine, Life Extension.
"We feel that the inclusion of Calcium D-Glucarate in Life
Extension Foundation's product is a outstanding match," stated David
T. Howard, Nutraceutix president and chief executive officer. "Calcium
D-Glucarate is a beneficial phytonutrient designed to facilitate one
of the body's major detoxification and elimination pathways for
potentially harmful environmental toxins.
"Life Extension Foundation has been advocating health and wellness
for several decades, and Calcium D-Glucarate certainly fits nicely
with their current product lineup."
Calcium D-Glucarate is the patented form of glucaric acid, a
phytonutrient found naturally in grapefruit, apples, oranges, broccoli
and brussel sprouts. Researchers have determined that supplemental
Calcium D-Glucarate promotes glucuronidation, one of the major
processes by which the body eliminates potentially harmful substances
and chemicals; thereby, protecting it from environmental toxins.
Calcium D-Glucarate promotes health by inhibiting
beta-glucuronidase, an enzyme that forms in the body and which hinders
glucuronidation. If beta-glucuronidase levels go unchecked, they may
not only reverse glucuronidation but allow toxins to remain in the
body to potentially cause cell damage.
According to the cover story, "What's Missing From Multi-Vitamin
Supplements?" in the November 2000 issue of Life Extension, beneficial
phytonutrients, such as Calcium D-Glucarate, help combat the numerous
carcinogens, such as pesticides, over-cooked food, alcohol, food
additives, tobacco, fungal mutagens and industrial pollutants, the
body is exposed to regularly.
D-Glucarate is distinguished from antioxidants in that it supports
detoxification and elimination of potentially harmful toxins while
providing protection against the "mutating effects that these
carcinogens induce on cellular DNA."
Nutraceutix supplies Calcium D-Glucarate to quality companies in
the nutritional supplement industry such as Boehringer Ingelheim,
Enzymatic Therapy, Natrol, Nature's Way, Rexall Showcase, Twin Labs,
Tyler Encapsulation, and many more. Nutraceutix' quality assurance
program routinely monitors Calcium D-Glucarate products sold via U.S.
retailers.
Nutraceutix has incorporated an identification marker on its
Calcium D-Glucarate as part of its ongoing efforts to ensure consumers
receive only the patented material, which is the material used in
research and clinical studies conducted at the AMC Cancer Research
Center, Denver, and MD Anderson Cancer Center, Houston.
Nutraceutix Inc. possesses proven technologies and products for
the nutraceutical and pharmaceutical industries. In addition to
patented ingredients like Calcium D-Glucarate, Nutraceutix provides
patented and proprietary technologies including CDT(TM) Controlled
Delivery Technology, MDT(TM)Molecular Dispersion Technology,
SET(TM)Self Emulsifying Technology, and LiveBac(R)Probiotics.
Nutraceutix technologies provide distinctive supplements with
competitive commercial advantages and tangible benefits for the
consumer. Nutraceutix: Improving Nutrition. Improving Lives.
Except for any historical information, the matters discussed in
this press release contain forward-looking statements, including
activities, events or developments that the company expects, believes
or anticipates will or may occur in the future. Such statements are
subject to a number of assumptions, risks and uncertainties.
Readers are cautioned that such statements are not guarantees of
future performance and that actual results or developments may differ
materially from those set forth in the forward-looking statement.
--30--sls/ix*
CONTACT: ignite marketing group
Margaret Anderson, 480/785-5252
margaret@ignitemg.com
www.nutraceutix.com
KEYWORD: WASHINGTON COLORADO TEXAS
INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
*** end of story *** |
